Literature DB >> 15208141

Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas.

Gary M Israel1, Melvyn Korobkin, Chun Wang, Elizabeth N Hecht, Glenn A Krinsky.   

Abstract

OBJECTIVE: Our aim was to evaluate adrenal adenomas in patients who underwent both unenhanced CT and chemical shift MRI to determine if adenomas can be characterized with MRI when the findings of CT are indeterminate.
MATERIALS AND METHODS: Between January 1999 and June 2003, 40 patients (42 adrenal masses) underwent unenhanced CT and chemical shift MRI and were retrospectively analyzed. Hounsfield units, adrenal-to-spleen chemical shift ratio, and signal-intensity index were obtained for each adrenal mass. Qualitative analysis for loss of signal in each adrenal mass on the opposed-phase images was also performed by two reviewers and compared with the quantitative analyses. A lipid-rich adenoma was diagnosed if the mass measured equal to or less than 10 H, had an adrenal-to-spleen chemical shift ratio of less than 0.71, and had a signal-intensity index of greater than 16.5% or if the mass fulfilled two of the preceding criteria and had follow-up imaging without change.
RESULTS: The sensitivities and specificities for diagnosing a lipid-rich adenoma using the qualitative, adrenal-to-spleen chemical shift ratio, signal-intensity index, and unenhanced CT attenuation analyses were 92% (33/36) and 17% (1/6), 100% (36/36) and 100% (6/6), 100% (36/36) and 67% (4/6), and 78% (28/36) and 83% (5/6), respectively. Twenty-eight (67%) lipid-rich adenomas measured equal to or less than 10 H, had an adrenal-to-spleen chemical shift ratio of less than 0.71, and had a signal-intensity index of greater than 16.5%. Eight masses (19%) measured greater than 10 H but had an adrenal-to-spleen chemical shift ratio of less than 0.71 and a signal-intensity index greater than 16.5% and were unchanged at follow-up.
CONCLUSION: Eight (62%) of 13 adrenal adenomas measuring greater than 10 H on unenhanced CT were definitively characterized with chemical shift MRI.

Entities:  

Mesh:

Year:  2004        PMID: 15208141     DOI: 10.2214/ajr.183.1.1830215

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  24 in total

Review 1.  FDG PET in the management of patients with adrenal masses and adrenocortical carcinoma.

Authors:  Désirée Deandreis; Sophie Leboulleux; Caroline Caramella; Martin Schlumberger; Eric Baudin
Journal:  Horm Cancer       Date:  2011-12       Impact factor: 3.869

Review 2.  Conventional imaging in adrenocortical carcinoma: update and perspectives.

Authors:  William F Young
Journal:  Horm Cancer       Date:  2011-12       Impact factor: 3.869

Review 3.  Dual energy CT: preliminary observations and potential clinical applications in the abdomen.

Authors:  Anno Graser; Thorsten R C Johnson; Hersh Chandarana; Michael Macari
Journal:  Eur Radiol       Date:  2008-08-02       Impact factor: 5.315

4.  Cross-sectional imaging work-up of adrenal masses.

Authors:  Brinda Rao Korivi; Khaled M Elsayes
Journal:  World J Radiol       Date:  2013-03-28

Review 5.  Surgical management of adrenal metastases.

Authors:  Juan J Sancho; Frédéric Triponez; Xavier Montet; Antonio Sitges-Serra
Journal:  Langenbecks Arch Surg       Date:  2011-12-16       Impact factor: 3.445

Review 6.  Diagnostic accuracy of 18F-FDG PET or PET/CT for the characterization of adrenal masses: a systematic review and meta-analysis.

Authors:  Seong-Jang Kim; Sang-Woo Lee; Kyoungjune Pak; In-Ju Kim; Keunyoung Kim
Journal:  Br J Radiol       Date:  2018-02-05       Impact factor: 3.039

Review 7.  Adrenal imaging for adenoma characterization: imaging features, diagnostic accuracies and differential diagnoses.

Authors:  Jung Jae Park; Byung Kwan Park; Chan Kyo Kim
Journal:  Br J Radiol       Date:  2016-03-02       Impact factor: 3.039

8.  Pediatric adrenocortical neoplasms: can imaging reliably discriminate adenomas from carcinomas?

Authors:  Kelsey A Flynt; Jonathan R Dillman; Matthew S Davenport; Ethan A Smith; Tobias Else; Peter J Strouse; Elaine M Caoili
Journal:  Pediatr Radiol       Date:  2015-03-21

Review 9.  The indeterminate adrenal lesion.

Authors:  Anju Sahdev; Jon Willatt; Isaac R Francis; Rodney H Reznek
Journal:  Cancer Imaging       Date:  2010-03-18       Impact factor: 3.909

10.  Comparison of MRI features in lipid-rich and lipid-poor adrenal adenomas using subjective and quantitative analysis.

Authors:  Wendy Tu; Rosalind Gerson; Jorge Abreu-Gomez; Amar Udare; Rachel Mcphedran; Nicola Schieda
Journal:  Abdom Radiol (NY)       Date:  2021-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.